Phase 2: Acoustic Cluster Therapy (ultrasound-triggered microbubble enhancer) in pancreatic cancer.

This Phase 2 trial evaluates the safety and efficacy of combining Acoustic Cluster Therapy with modified FOLFIRINOX in patients with locally advanced, unresectable pancreatic cancer. Acoustic Cluster Therapy uses ultrasound-triggered microbubbles to potentially enhance chemotherapy delivery. Sponsored by EXACT Therapeutics AS, the study explores a novel approach to improve treatment outcomes.